Director/PDMR Shareholding
31 October 2024
RWS Holdings plc
Notification and public disclosure of transactions by PDMRs
RWS Holdings plc ("RWS" or "the Company"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces that it has been informed that Ian El-Mokadem, Chief Executive Officer, has acquired 5,000 ordinary shares of 1 pence each in the Company ("Shares") at a price of 149.4 pence.
Following this share purchase, Ian El-Mokadem has a total beneficial interest in 200,000 Shares.
This announcement is made in accordance with Article 19(3) of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).
For further information, please contact:
RWS Holdings plc Julie Southern, Chairman Ian El-Mokadem, Chief Executive Officer |
01753 480200 |
MHP (Financial PR advisor) Katie Hunt / Eleni Menikou |
020 3128 8100 07884 494112 |
Deutsche Numis (Nomad & Joint Broker) Stuart Skinner / William Wickham
|
020 7260 1000
|
Berenberg (Joint Broker) Ben Wright / Toby Flaux / Milo Bonser |
020 3207 7800
|
About RWS:
RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.
Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.
Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.
We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.
Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).
For further information, please visit: www.rws.com.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Ian El-Mokadem | ||||
2. | Reason for the notification | |||||
a. | Position/status | Chief Executive Officer | ||||
b. | Initial notification/Amendment | Initial Announcement | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | RWS Holdings plc | ||||
b. | LEI | 213800YGBGTTSKUVK111 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 1p each GB00BVFCZV34 | ||||
b. | Nature of the transaction | Purchase of shares | ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information · Aggregated volume · Price |
N/A single transaction | ||||
e. | Date of the transaction | 31 October 2024 | ||||
f. | Place of the transaction | London Stock Exchange
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.